Hints and tips:
Related Special Reports
...The Anglo-Swedish drugmaker AstraZeneca has drawn up plans to split off its China business and list it separately as a way to shelter the company from the worsening relationship between China and the west...
...News round-up Calpers to invest more than $30bn in private markets (FT) Telegraph takeover by RedBird IMI faces regulatory probe (FT) Gucci owner Kering issues rare luxury sector profit warning (FT) AstraZeneca...
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
...AstraZeneca also has a secondary listing in New York....
...AstraZeneca said in February it had chosen to open a $360mn factory in Ireland, rather than in the UK, because of a “discouraging tax rate”, while German drugmaker Bayer said last year that it had cut staff...
...The company has raised $500mn from investors since being created and has signed partnerships with AstraZeneca and life insurance companies such as Discovery and Massachusetts Mutual....
...Spirax-Sarco, a top engineering group, and AstraZeneca, the pharmaceuticals producer, sit at more than £90 for a single share....
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
...The original agreement was signed in 2021 as the world grappled with a shortage of jabs and the EU became concerned about delays to the delivery of vaccines from Oxford/AstraZeneca and other suppliers....
...“The idea is to use the subsidiaries of AstraZeneca as a leverage to gain a greater reach around the world,” Dunoyer told the Financial Times....
...The shot had also been seen as a potentially significant contributor to the global vaccine access scheme Covax, after AstraZeneca temporarily paused deliveries, though demand for shots weakened as the pandemic...
...AstraZeneca’s Lynparza, which is used for multiple tumour types, has just won EU approval for advanced prostate cancer. The group scored another notable success with Enhertu....
...Regeneron has also partnered with AstraZeneca for its expertise in chemistry, to make a pill, and with Boston-based Alnylam Pharmaceuticals, to use its novel way of silencing genes, called RNA interference...
...A deal between the California-based biotech and Horizon, which is headquartered in Ireland, would mark the largest pharmaceutical transaction since AstraZeneca bought Alexion for $39bn last year....
...The deal is the largest pharmaceutical transaction since AstraZeneca bought Alexion for $39bn last year and could signal a rebound in mergers and acquisitions following a dip in activity this year, according...
...That is not the case with the vaccine made from a modified adenovirus by AstraZeneca/Oxford university. Nonetheless, AstraZeneca’s jab comes second only to BioNTech/Pfizer’s shot in terms of orders....
...An additional bonus is knowing that Carayol — a former board director of IPC Media, now Time Inc — has previously walked in the same shoes. “Our exchanges are always open and frank,” Maso states....
...ABB’s dominant quote is in Swiss francs and for AstraZeneca, even when London’s on holiday, the Cboe sterling quotation provides the reference....
...Vaccitech, which owns the underlying technology behind the Oxford/AstraZeneca Covid-19 jab, went public last year on the Nasdaq....
...AstraZeneca said patient safety was of the “utmost importance” and it worked with regulators to monitor safety information....
...The letter was sent to the boards of Pfizer, Moderna, AstraZeneca and Johnson & Johnson....
...But the Oxford/AstraZeneca and Valneva jabs lagged....
...shortage is challenging India’s IT companies, which serve as the foundation of the country’s services industry and as back offices to the world’s biggest companies, including Citibank UK, Microsoft and AstraZeneca...
...The changes are conditional upon AstraZeneca finalising its purchase of Alexion, likely in the third quarter....
...AstraZeneca’s innovation in oncology has helped turn round performance at the Anglo-Swedish drugmaker in recent years....
International Edition